Investigators compared outcomes among patients with psoriasis undergoing apremilast treatment with genital involvement versus those without genital involvement.
Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...
In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...
12d
News-Medical.Net on MSNMediterranean diet shows promise in easing psoriasis, acne, and hidradenitis suppurativaA recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...
The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...
A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...
6d
News-Medical.Net on MSNNatural product derivative demonstrates promising therapeutic potential for psoriasisAnnouncing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...
A mother-of-two claims to have found a "miracle" cure for her psoriasis almost three decades after first being diagnosed with ...
Korea: A recent retrospective cohort study published in the Journal of the American Academy of Dermatology explored the link ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results